The conclusion of the relationship between vascular endothelial growth factor gene polymorphism and renal cell carcinoma risk was inconsistent. This study was performed to assess the relationship between vascular endothelial growth factor gene polymorphism and renal cell carcinoma risk using meta-analysis. The association studies were identified from PubMed, Embase, and Web of Science, and eligible studies were included and calculated. Ten studies were included for this meta-analysis. vascular endothelial growth factor (VEGF) þ405G > CC allele and GG genotype were associated with renal cell carcinoma risk for overall populations in this meta-analysis (C allele: odds ratio ¼ 1.18, 95% confidence interval: 1.05-1.33, P ¼ .004; CC genotype: odds ratio ¼ 1.20, 95% confidence interval: 0.96-1.50, P ¼ .12; GG genotype: odds ratio ¼ 0.79, 95% confidence interval: 0.67-0.93, P ¼ .004). Furthermore, VEGF þ936C>T gene polymorphism and VEGF À2578 C>A gene polymorphism were associated with renal cell carcinoma risk for overall populations (þ936C>T: T allele: odds ratio ¼ 1.16, 95% confidence interval: 1.05-1.29, P ¼ .004; TT genotype: odds ratio ¼ 1.25, 95% confidence interval: 1.02-1.52, P ¼ .03; CC genotype: odds ratio ¼ 0.86, 95% confidence interval: 0.75-0.98, P ¼ .03; À2578 C>A: A allele: odds ratio ¼ 1.26, 95% confidence interval: 1.15-1.38, P < .00001; AA genotype: odds ratio ¼ 1.39, 95% confidence interval: 1.16-1.67, P ¼ .0004; CC genotype: odds ratio ¼ 0.75, 95% confidence interval: 0.61-0.92, P ¼ .006). However, VEGF À634G>C, VEGF À460T>C, VEGF À1154 G>A, and VEGF þ1612 G>A gene polymorphisms were not associated with renal cell carcinoma risk. In conclusion, VEGF þ405G>CC allele and GG genotype, VEGF þ936C>T gene polymorphism, and VEGF À2578 C>A gene polymorphism were associated with renal cell carcinoma risk for overall populations. However, more studies should be performed to assess this relationship in the future.
Introduction
Renal cell carcinoma, one of the most malignant tumors, affects men more frequently than women and constitutes nearly 90% of all kidney tumors. 1 The incidence of renal cell carcinoma varies geographically: the highest level is recorded in Europe, North America, and Australia, the lowest in Africa, India, China, and Japan. 1 Diagnosis of renal cell carcinoma at an early stage is challenging, but it can provide the best chance for cure. 2 Renal cell carcinoma, a metabolic disease, being characterized by the dysregulation of metabolic pathways involved in oxygen sensing Von Hippel-Lindau/hypoxia inducible factor (VHL/HIF pathway alterations and the subsequent upregulation of HIF-responsive genes, such as vascular endothelial growth factor [VEGF]).
Vascular endothelial growth factor, an important signaling proteins involved in angiogenesis, can influence on the development of physiological and pathological tissue. 4 Angiogenesis is an essential physiological process, and it is an important factor in disease pathogenesis. Vascular endothelial growth factor pathway is reported to play a conspicuous role in the growth and progression of human cancers, such as renal cell carcinoma. [5] [6] [7] VEGF þ405G>C, VEGF À634G>C, VEGF À460T>C, VEGF þ936C>T, VEGF À2578 C>A, VEGF À1154 G>A, VEGF þ1612 G>A gene polymorphisms were the important gene types for VEGF. The current evidences indicate that VEGF þ405G>C, VEGF À634G>C, VEGF À460T>C, VEGF þ936C>T, VEGF À2578 C>A, VEGF À1154 G>A, and VEGF þ1612 G>A gene polymorphisms might take part in the pathogenesis of carcinogenesis. This meta-analysis was performed to assess the relationship between VEGF þ405G>C, VEGF À634G>C, VEGF À460T>C, VEGF þ936C>T, VEGF À2578 C>A, VEGF À1154 G>A, VEGF þ1612 G>A gene polymorphisms and renal cell carcinoma risk.
Materials and Methods

Search Strategy
The relevant investigation were searched and included from the databases of PubMed, Embase, and Web of Science, on July 1, 2016. The retrieval strategy of "(vascular endothelial growth factor OR VEGF) AND (renal cell carcinoma OR renal carcinoma) AND (polymorphism OR polymorphisms)" was entered into these databases mentioned above. The additional reports were identified through references cited in recruited articles.
Inclusion and Exclusion Criteria
Inclusion criteria. (1) The outcome must be renal cell carcinoma, (2) the study included 2 comparison groups (renal cell carcinoma group vs control group), and (3) report should give the data of VEGF genotype distribution.
Exclusion criteria. (1) Case reports, review articles, and editorials; (2) preliminary result not on VEGF gene polymorphism or renal cell carcinoma; (3) investigating the role of VEGF gene expression to renal cell carcinoma.
Data Extraction
The following information from each eligible investigation was extracted by 2 investigators independently: first author's surname, year of publication, ethnicity, control source of the control group, and the number of cases and controls for VEGF genotypes. Frequencies of allele of VEGF were calculated for renal cell carcinoma group and control group. When the disagreement was occurred, the results would be resolved by discussion.
Statistical Analysis
Cochrane Review Manager Version 5 (Cochrane Library, United Kingdom) was used in this meta-analysis to calculate the extracted data from each report. The pooled statistic was counted using the fixed effects model. However, a random effects model was conducted when the P value of heterogeneity test was less than.1. Results were expressed using odds ratios (OR) for dichotomous data. Ninety-five percent confidence intervals (CIs) were also calculated. P <.05 was required for the pooled OR to be statistically significant, and I 2 was used to test the heterogeneity among the included studies. A w 2 test using a web-based program was applied to determine whether the genotype distribution of the control population reported for VEGF þ936C>T conformed to Hardy-Weinberg equilibrium (HWE; P <.05 was considered significant). Sensitivity analysis was performed if HWE disequilibrium existed.
Results
Association of VEGF þ405G>C Gene Polymorphism With Renal Cell Carcinoma Risk
Three studies [8] [9] [10] for the relationship between VEGF þ405G>C gene polymorphism and renal cell carcinoma risk were included in this meta-analysis, and the extracted data were shown in Table 1 Table 2 ).
In the subgroup analysis by ethnicity, this meta-analysis indicated that VEGF þ405G>CC allele and GG genotype were associated with renal cell carcinoma risk in Asian population but not in CC genotype (Table 2 ). However, VEGF þ405G>C gene polymorphism was not associated with renal cell carcinoma susceptibility in Caucasian population ( Table 2) .
Association of VEGF À634G>C Gene Polymorphism With Renal Cell Carcinoma Risk
Four studies [11] [12] [13] [14] for the relationship between VEGF À634G>C gene polymorphism and renal cell carcinoma risk were included in this meta-analysis, and all studies were performed in Asian population (Table 1) . We found that VEGF À634G>C gene polymorphism was not associated with renal cell carcinoma risk in Asian population ( Table 2) .
Association of VEGF À460C >T Gene Polymorphism With Renal Cell Carcinoma Risk
Three studies 8, 9, 11 for the relationship between VEGF À460C>T gene polymorphism and renal cell carcinoma risk were included in this meta-analysis, and the extracted data were shown in Table 1 . We found that VEGF À460C>T gene polymorphism was not associated with renal cell carcinoma risk in overall populations (Table 2) .
In the subgroup analysis by ethnicity, this meta-analysis indicated that, in Asian population, VEGF À460C>TT allele and TT genotype were associated with renal cell carcinoma risk but not in CC genotype (Table 2) . However, VEGF À460C>T gene polymorphism was not associated with renal cell carcinoma risk in Caucasian population ( Table 2) .
Association of VEGF þ936C>T Gene Polymorphism With Renal Cell Carcinoma Risk
Seven studies 8, 9, [11] [12] [13] [14] [15] for the relationship between VEGF þ936C>T gene polymorphism and renal cell carcinoma risk were included in this meta-analysis, and the extracted data were shown in Table 1 . We found that VEGF þ936C>T gene polymorphism was associated with renal cell carcinoma risk in Figure 1 and Table 2 ). In the subgroup analysis by ethnicity, this meta-analysis indicated that, in Asian population, VEGF þ936C>TT allele and TT genotype were associated with renal cell carcinoma risk but not in CC genotype (Table 2) . However, VEGF þ936C>T gene polymorphism was not associated with renal cell carcinoma risk in Caucasian population (Table 2) .
Sensitivity analysis according to genotype distribution of the control population reported for VEGF þ936C>T gene polymorphism conformed to HWE for the relationship between VEGF þ936C>T gene polymorphism and renal cell carcinoma risk was performed. Two studies 11, 12 were not in HWE. We found that T allele, TT 
Association of VEGF À2578 C>A Gene Polymorphism With Renal Cell Carcinoma Risk
Six studies 9, [11] [12] [13] [14] 16 for the relationship between VEGF À2578 C>A gene polymorphism and renal cell carcinoma risk were included in this meta-analysis, and the extracted data were shown in Table 1 Figure 2 and Table 2 ).
In the subgroup analysis by ethnicity, this meta-analysis indicated that, in Asian population, VEGF À2578 C>A gene polymorphism was associated with renal cell carcinoma risk (Table 2) . However, VEGF À2578 C>A gene polymorphism was not associated with renal cell carcinoma risk in Caucasian population ( Table 2) .
Association of VEGF À1154 G>A Gene Polymorphism With Renal Cell Carcinoma Risk
Three studies 8, 14, 17 for the relationship between VEGF À1154 G>A gene polymorphism and renal cell carcinoma risk were included in this meta-analysis, and the extracted data were shown in Table 1 . We found that VEGF À1154 G>A gene polymorphism was not associated with renal cell carcinoma risk in overall populations (Table 2) .
In the subgroup analysis by ethnicity, this meta-analysis indicated that, in Asian population, VEGF À1154 G>A gene polymorphism was not associated with renal cell carcinoma risk (Table 2) . Furthermore, VEGF À1154 G>A gene polymorphism was also not associated with renal cell carcinoma risk in Caucasian population ( Table 2) .
Association of VEGF þ1612 G>A Gene Polymorphism With Renal Cell Carcinoma Risk
Four studies [11] [12] [13] 15 for the relationship between VEGF þ1612 G>A gene polymorphism and renal cell carcinoma risk were included in this meta-analysis, and all studies were performed in Asian population (Table 1) . We found that VEGF þ1612 G>A gene polymorphism was not associated with renal cell carcinoma risk in Asian population (Table 2) .
Discussion
In this meta-analysis, we found that VEGF þ405G>CC allele and GG genotype were associated with renal cell carcinoma risk, but CC genotype not in Asian population and in overall populations. However, VEGF þ405G>C gene polymorphism was not associated with renal cell carcinoma risk in Caucasians. However, there were only 3 included studies for this meta-analysis (1 for Asians and 2 for Caucasians). The results for the relationship between VEGF þ405G>C gene polymorphism and renal cell carcinoma risk might be less robust. More studies should be performed in the future.
In the meta-analysis for the relationship between VEGF À460T>C gene polymorphism and renal cell carcinoma risk, we found that VEGF À460T>C gene polymorphism was associated with renal cell carcinoma risk in Asian population. But, there was only one included studies for Asians, and the results might be less robust. However, VEGF À460T>C gene polymorphism was associated with renal cell carcinoma risk in Caucasians and in overall populations.
Interestingly, VEGF þ936C>TT allele and TT genotype were found to be associated with renal cell carcinoma risk in Asians and in overall populations, and CC genotype was associated with renal cell carcinoma risk in overall populations. The sample size for overall populations was 7 studies, and the sample size for Asians was 5 studies. We also tested the publication bias for Asians and overall populations and found there was no publication bias for Asians or for overall populations (data not shown). However, VEGF þ936C>T gene polymorphism was not associated with renal cell carcinoma risk in Caucasians, and there were only 2 included studies for the metaanalysis in Caucasians. The results for Caucasians should be confirmed in the future.
Furthermore, we also found that VEGF À2578 C>A gene polymorphism was associated with renal cell carcinoma risk in Asians and in overall populations. The sample size for overall populations was 6 studies, and the sample size for Asians was 5 studies. We also tested the publication bias for Asians and overall populations and also found there was no publication bias for Asians or for overall populations (data not shown). However, VEGF À2578 C>A gene polymorphism was not associated with renal cell carcinoma risk in Caucasians, and there was only one included study for the metaanalysis in Caucasians. The results for Caucasians should be retested in further.
This meta-analysis also indicated that VEGF À634G>C gene polymorphism and VEGF þ1612 G>A gene polymorphism were not associated with renal cell carcinoma risk in Asians. Furthermore, VEGF À1154 G>A gene polymorphism was not associated with renal cell carcinoma risk in Asians, in Caucasians, and in overall populations. The sample sizes for VEGF À634G>C gene polymorphism and VEGF þ1612 G>A gene polymorphism were 4, and the sample size for VEGF À1154 G>A gene polymorphism was 3. More studies should be conducted in the future.
In previous, Zhang et al 18 performed a meta-analysis including 5 studies and indicated that the VEGF þ936C>T (including 3 studies), þ1612 G>A (including 1 study), À1154 G>A (including 2 studies), À460T>C (including 2 studies), and þ405G>C (including 2 studies) gene polymorphisms were not associated with the risk of renal cell carcinoma, and À2578 C>A gene polymorphism might be associated with an increased risk of renal cell carcinoma (including 2 studies). The sample sizes in our meta-analysis were larger than those for Zhang et al. 18 The results from our meta-analysis might be more robust. Furthermore, we first conducted the meta-analysis for the relationship between VEGF À634G>C gene polymorphism and the risk of renal cell carcinoma (including 4 studies) and reported that VEGF À634G>C gene polymorphism was not associated with renal cell carcinoma risk in Asians.
Nie et al 19 performed a hospital-based case-control study, analyzed peripheral venous blood collected from 100 patients with cutaneous squamous cell carcinoma (cSCC) and 124 healthy controls, and reported that VEGF gene À460 C>T polymorphism and À1154 G>A polymorphism may serve as potential genetic markers for the risk and prognosis of cSCC. Rezaei et al 20 performed a study aimed to evaluate the impact of VEGF rs3025039 (þ936C>T), rs2010963 (þ405C>G), rs833061 (À460T>C), rs699947 (À2578C>A), and rs35569394 (18-bp I/D) polymorphisms on breast cancer (BC) risk in an Iranian population in southeast of Iran and reported that VEGF rs699947 polymorphism may increase the risk of BC development. Bingül et al 21 isolated the DNA from peripheral blood leukocytes of 127 patients with papillary thyroid carcinoma (PTC) and 203 healthy controls and reported that VEGF Gþ405C polymorphism is associated with an increased risk of PTC. In different cancers, the relationship might be different.
However, there were some limitations in our metaanalyses, due to the lack of heterogeneity analysis, sensitivity analysis, and publication bias of the pooling OR. For the result that the sample size of included studies was small, and it was difficult to state that different cancers have different incidence in different population, have you ever considered the prevalence and ethnics.
In conclusion, VEGF þ405G>CC allele, þ405G>C GG genotype, VEGF À2578 C>A gene polymorphism, VEGF þ936C>TT allele, and VEGF þ936C>T TT genotype were associated with renal cell carcinoma risk in Asian population and in overall populations. Furthermore, VEGF À460T>C gene polymorphism was associated with renal cell carcinoma risk in Asian population, and CC genotype was associated with renal cell carcinoma risk in overall populations. However, more association studies are required to clarify this relationship further.
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